Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...

Inspire Medical ( (INSP) ) has released its Q3 earnings. Here is a breakdown of the information Inspire Medical presented to its investors.

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

(Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today ...

At this time, I'd like to welcome everyone to the Inspire Medical Systems Third Quarter 2024 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ ...

Dr. Wise from CAMC not only offers ‘Inspire’ therapy to treat his patients' sleep apnea - he’s also using ‘Inspire’ to treat ...

Inspire expects full-year earnings to be $1.20 to $1.40 per share, with revenue in the range of $793 million to $798 million. This story was generated by Automated Insights ( ...